The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926)

Toxicology

Volumn 218, Issue 1, 2006, Pages 30-38

  Kilic, Bülent ^a   Kruse, Matthias ^a   Stahlmann, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD34; Cell adhesion molecules; Dalfopristin; Erythromycin; Infusion phlebitis; Levofloxacin; Quinupristin

Indexed keywords

ALPHA2 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA4 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; DALFOPRISTIN PLUS QUINUPRISTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERYTHROMYCIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LEVOFLOXACIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTI-BACTERIAL AGENTS; CELL ADHESION MOLECULES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ERYTHROMYCIN; FLOW CYTOMETRY; HUMANS; OFLOXACIN; PHLEBITIS; VIRGINIAMYCIN;

EID: 28844439688     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.09.014     Document Type: Article

References (47)

1. R.G. Andrews, J.W. Singer, and I.D. Bernstein Monoclonal antibody 12-8 recognizes a 115 kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors Blood 67 1986 842 845
2. S. Baumhueter, N. Dybdal, C. Kyle, and L.A. Lasky Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin Blood 84 1994 2554 2565
3. W.E. Beschorner, C.I. Civin, and L.C. Strauss Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody Am. J. Pathol. 119 1985 1 4
4. R.C. Bone Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation Crit. Care Med. 24 1996 163 172
5. J. Brown, M.F. Greaves, and H.V. Molgaard The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts Int. Immunol. 3 1991 175 184
6. C. Carbon Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47 9-14 2001 44 48 (discussion)
7. T.M. Carlos, and J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101
8. P.L. Carver, E. Whang, H.L. Van den Bussche, C.A. Kauffmann, and P.L. Malani Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy Pharmacotherapy 23 2003 159 164
9. C.I. Civin, L.C. Strauss, C. Brovall, M.J. Fackler, J.F. Schwartz, and J.H. Shaper Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells J. Immunol. 133 1984 157 165
10. A. Dalhoff, and I. Shalit Immunomodulatory effects of quinolones Lancet Infec. Dis. 3 2003 359 371
11. D. Delia, M.G. Lampugnani, M. Resnati, E. Dejana, A. Aiello, E. Fontanella, D. Soligo, M.A. Pierotti, and M.F. Greaves CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro Blood 81 1993 1001 1008
12. L.L. Dever, S.M. Smith, D. Dejesus, M. Masurekar, D. Patel, Z.C. Kaminski, and W.G. Johanson Jr. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of 15 cases Microb. Drug Resist. 2 1996 407 413
13. E.A. de Wynter, A.J. Emmerson, and N.G. Testa Properties of peripheral blood and cord blood stem cells Bailliere. Best Pract. Res. Clin. Haematol. 12 1999 1 17
14. I. Engelberts, A. Moller, J.F. Leeuwenberg, C.J. van der Linden, and W.A. Buurman Administration of tumor necrosis factor alpha (TNF-α) inhibitors after exposure to TNF-α prevents development of the maximal biological effect: an argument for clinical treatment with TNF-α inhibitors J. Surg. Res. 53 1992 510 514
15. T.M. File Jr., J. Segreti, L. Dunbar, R. Player, R. Kohler, R.R. Williams, C. Kojak, and A. Rubin A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia Antimicrob. Agents Chemother. 41 1997 1965 1972
16. L. Fina, H.V. Molgaard, D. Robertson, N.J. Bradley, P. Monaghan, D. Delia, D.R. Sutherland, M.A. Baker, and M.F. Greaves Expression of the CD34 gene in vascular endothelial cells Blood 75 1990 2417 2426
17. V.G. Gorgoulis, P. Zacharatos, A. Kotsinas, D. Kletsas, G. Mariatos, V. Zoumpourlis, K.M. Ryan, C. Kittas, and A.G. Papavassiliou p53 Activates ICAM-1 (CD54) expression in an NF-κB independent manner EMBO J. 22 2003 1567 1578
18. D.E. Hallahan, S. Virudachalam, and J. Kuchibhotla Nuclear factor-κB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium Cancer Res. 58 1998 5484 5488
19. + hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting Cytometry 14 1993 384 392
20. A.A. Khan, T.R. Slifer, and J.S. Remington Effect of trovafloxacin on production of cytokines by human monocytes Antimicrob. Agents Chemother. 42 1998 1713 1717
21. A.A. Khan, T.R. Slifer, F.G. Araujo, and J.S. Remington Effect of clarithromycin and azithromycin on production of cytokines by human monocytes Int. J. Antimicrob. Agents 11 1999 121 132
22. A.A. Khan, T.R. Slifer, F.G. Araujo, and J.S. Remington Effect of quinupristin/dalfopristin on production of cytokines by human monocytes J. Infect. Dis. 182 2000 356 358
23. D.S. Krause, M.J. Fackler, C.I. Civin, and W.S. May CD34: structure, biology, and clinical utility Blood 87 1996 1 13
24. J.M. Kuldo, J. Westra, S.A. Asgeirsdottir, R.J. Kok, K. Oosterhuis, M.G. Rots, J.P. Schouten, P.C. Limburg, and G. Molema Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α and IL-1β induced pro-inflammatory status of endothelial cells in vitro Am. J. Physiol. Cell Physiol. 2005 (Epub. ahead of print)
25. M.T. Labro, and H. Abdelghaffar Immunomodulation by macrolide antibiotics J. Chemother. 13 2001 3 8
26. P. Lanbeck, I. Odenholt, and O. Paulsen Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study Scand. J. Infect. Dis. 34 2002 512 519
27. P. Lanbeck, I. Odenholt, and K. Riesbeck Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis J. Antimicrob. Chemother. 53 2004 174 179
28. H.D. Langtry, and H.M. Lamb Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract Drugs 56 1998 487 515
29. G.B. Lewis, and J.F. Hecker Infusion thrombophlebitis Br. J. Anaesth. 57 1985 220 233
30. E.A. Lidington, D.L. Moyes, A.M. McCormack, and M.L. Rose A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions Transpl. Immunol. 7 1999 239 246
31. M. Monreal, F. Quilez, C. Rey-Joly, S. Rodriguez, N. Sopena, C. Neira, and J. Roca Infusion phlebitis in patients with acute pneumonia: a prospective study Chest 115 1999 1576 1580
32. M. Mutin, F. Dignat-George, and J. Sampol Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules Tissue Antigens 50 1997 449 458
33. B.J. Nickoloff The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma Arch. Dermatol. 127 1991 523 529
34. K. Ohlsson, P. Bjork, M. Bergenfeldt, R. Hageman, and R.C. Thompson Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550 552
35. S.J. Rehm, D.R. Graham, L. Srinath, P. Prokocimer, M.P. Richard, and G.H. Talbot Successful administration of quinupristin/dalfopristin in the outpatient setting J. Antimicrob. Chemother. 47 2001 639 645
36. K.A. Roebuck, and A. Finnegan Regulation of intercellular adhesion molecule-1 (CD54) gene expression J. Leukoc. Biol. 66 1999 876 888
37. E. Rubinstein, P. Prokocimer, and G.H. Talbot Safety and tolerability of quinupristin/dalfopristin: administration guidelines J. Antimicrob. Chemother. 44 1999 37 46
38. P. Sriramarao, C.R. Norton, P. Borgstrom, R.G. Di Scipio, B.A. Wolitzky, and D.H. Broide E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo J. Immunol. 157 1996 4672 4680
39. R. Stahlmann, and H. Lode Toxicity of quinolones Drugs 58 1999 37 42
40. R. Stahlmann Veträglichkeit von Quinupristin-Dalfopristin Chemother. J. 9 2000 86 89
41. B. Sun, H. Fan, T. Honda, R. Fujimaki, A. Lafond-Walker, Y. Masui, C.J. Lowenstein, and L.C. Becker Activation of NF-κB and expression of ICAM-1 in ischemic-reperfused canine myocardium J. Mol. Cell. Cardiol. 33 2001 109 119
42. R.E. Unger, V. Krump-Konvalinkova, and K. Peters In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R Microvasc. Res. 64 2002 384 397
43. M.T. Voso, T.C. Burn, G. Wulf, B. Lim, G. Leone, and D.G. Tenen Inhibition of hematopoiesis by competitive binding of transcription factor PU.1 Proc. Natl. Acad. Sci. USA 91 1994 7932 7936
44. J. Whelan Selectin synthesis and inflammation Trends Biochem. Sci. 21 1996 65 69
45. S.H. Yalkowsky, J.F. Krzyzaniak, and G.H. Ward Formulation-related problems associated with intravenous drug delivery J. Pharm. Sci. 87 1998 787 796
46. M. Yoshida, S. Takayama, and M. Kato Effect of levofloxacin and ciprofloxacin injection on permeability of the tail vein in mice and skin microvasculature in rats Int. J. Tiss. Reac. 16 1994 105 112
47. T. Yoshimoto, K. Nakanishi, S. Hirose, K. Hiroishi, H. Okamura, Y. Takemoto, A. Kanamaru, T. Hada, T. Tamura, and E. Kakishita High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor J. Immunol. 148 1992 3596 3603